This company listing is no longer active
Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
DSM Stoklara Genel Bakış
Provides solutions for nutrition, health, and beauty businesses in the Switzerland, Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia.
Kar Tanesi Skoru | |
---|---|
Değerleme | 6/6 |
Gelecekteki Büyüme | 4/6 |
Geçmiş Performans | 1/6 |
Finansal Sağlık | 6/6 |
Temettüler | 3/6 |
Ödüller
Risk Analizi
DSM-Firmenich AG Rakipler
Fiyat Geçmişi ve Performans
Tarihsel hisse senedi fiyatları | |
---|---|
Güncel Hisse Fiyatı | €114.05 |
52 Haftanın En Yüksek Seviyesi | €160.10 |
52 Haftanın En Düşük Seviyesi | €105.80 |
Beta | 0.72 |
11 Aylık Değişim | -3.96% |
3 Aylık Değişim | -4.32% |
1 Yıllık Değişim | -26.49% |
33 Yıllık Değişim | -3.96% |
5 Yıllık Değişim | 28.70% |
Halka arzdan bu yana değişim | 1,649.00% |
Son Haberler & Güncellemeler
Recent updates
Analyst Forecasts For Koninklijke DSM N.V. (AMS:DSM) Are Surging Higher
May 04Koninklijke DSM (AMS:DSM) Is Reinvesting At Lower Rates Of Return
Mar 27Is Koninklijke DSM (AMS:DSM) A Risky Investment?
Mar 09Here's Why We Think Koninklijke DSM (AMS:DSM) Is Well Worth Watching
Dec 06Is Koninklijke DSM (AMS:DSM) Using Too Much Debt?
Nov 18Estimating The Fair Value Of Koninklijke DSM N.V. (AMS:DSM)
Oct 31Why Koninklijke DSM N.V. (AMS:DSM) Could Be Worth Watching
Sep 19Is Now The Time To Put Koninklijke DSM (AMS:DSM) On Your Watchlist?
Aug 23Is Koninklijke DSM (AMS:DSM) Using Too Much Debt?
Aug 08Calculating The Intrinsic Value Of Koninklijke DSM N.V. (AMS:DSM)
Jul 23Koninklijke DSM (AMS:DSM) Is Increasing Its Dividend To €1.70
Apr 30Koninklijke DSM (AMS:DSM) Is Increasing Its Dividend To €1.70
Apr 16Koninklijke DSM's (AMS:DSM) Upcoming Dividend Will Be Larger Than Last Year's
Apr 02Koninklijke DSM's (AMS:DSM) Dividend Will Be Increased To €1.70
Mar 19Koninklijke DSM (AMS:DSM) Seems To Use Debt Rather Sparingly
Feb 19Are Koninklijke DSM N.V. (AMS:DSM) Investors Paying Above The Intrinsic Value?
Nov 23We Think Koninklijke DSM (AMS:DSM) Can Stay On Top Of Its Debt
Oct 01Does This Valuation Of Koninklijke DSM N.V. (AMS:DSM) Imply Investors Are Overpaying?
Aug 24Koninklijke DSM (AMS:DSM) Has A Pretty Healthy Balance Sheet
Jun 29Koninklijke DSM N.V.'s (AMS:DSM) Intrinsic Value Is Potentially 17% Below Its Share Price
May 24Is Koninklijke DSM (AMS:DSM) A Risky Investment?
Mar 29Should Koninklijke DSM N.V. (AMS:DSM) Be Part Of Your Dividend Portfolio?
Mar 15Are Koninklijke DSM N.V.'s (AMS:DSM) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
Mar 01Koninklijke DSM (AMS:DSM) Has Gifted Shareholders With A Fantastic 276% Total Return On Their Investment
Feb 16Need To Know: Koninklijke DSM N.V. (AMS:DSM) Insiders Have Been Selling Shares
Feb 04Hissedar Getirileri
DSM | NL Chemicals | NL Pazar | |
---|---|---|---|
7D | 0.3% | -1.1% | 0.3% |
1Y | -26.5% | 25.8% | 25.6% |
Getiri vs. Endüstri: DSM underperformed the Dutch Chemicals industry which returned -20.7% over the past year.
Getiri vs Piyasa: DSM underperformed the Dutch Market which returned 9.1% over the past year.
Fiyat Oynaklığı
DSM volatility | |
---|---|
DSM Average Weekly Movement | 3.2% |
Chemicals Industry Average Movement | 3.6% |
Market Average Movement | 4.2% |
10% most volatile stocks in NL Market | 7.3% |
10% least volatile stocks in NL Market | 2.3% |
İstikrarlı Hisse Senedi Fiyatı: DSM has not had significant price volatility in the past 3 months.
Zaman İçindeki Volatilite: DSM's weekly volatility (3%) has been stable over the past year.
Şirket Hakkında
Kuruldu | Çalışanlar | CEO | Web sitesi |
---|---|---|---|
1902 | 19,973 | Dimitri de Vreeze | www.dsm-firmenich.com |
DSM-Firmenich AG Temel Bilgiler Özeti
DSM temel i̇stati̇sti̇kler | |
---|---|
Piyasa değeri | €763.73m |
Kazançlar(TTM) | €454.00m |
Gelir(TTM) | €8.39b |
1.7x
F/K Oranı0.1x
P/S OranıDSM aşırı değerli mi?
Gerçeğe Uygun Değer ve değerleme analizine bakınızKazanç ve Gelir
DSM gelir tablosu (TTM) | |
---|---|
Gelir | €8.39b |
Gelir Maliyeti | €5.70b |
Brüt Kâr | €2.69b |
Diğer Giderler | €2.24b |
Kazançlar | €454.00m |
Son Raporlanan Kazançlar
Dec 31, 2022
Sonraki Kazanç Tarihi
Aug 02, 2023
Hisse başına kazanç (EPS) | 67.80 |
Brüt Marj | 32.06% |
Net Kâr Marjı | 5.41% |
Borç/Özkaynak Oranı | 26.6% |
DSM uzun vadede nasıl bir performans gösterdi?
Geçmiş performansı ve karşılaştırmayı görün